Nalbuphine Hydrochloride NDC 71872-7320

NDC codes

FDA NDC Directory

Product NDC (as listed)71872-7320Labeler and product segments. Claims need a package NDC.

Product NDC at billing width71872-7320Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
71872-7320-1	71872732001	1 CARTON in 1 BAG (71872-7320-1) / 1 VIAL, MULTI-DOSE in 1 CARTON / 10 mL in 1 VIAL, MULTI-DOSEMarketed from Dec 15, 2023

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Nalbuphine Hydrochloride
Generic name (nonproprietary): nalbuphine hydrochloride
Active ingredients: Nalbuphine hydrochloride — 20 mg/mL
Dosage form: Injection, Solution
Route: Intramuscular, Intravenous, Subcutaneous
Labeler: Medical Purchasing Solutions, LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 070918
Marketing start: May 16, 2005
Listing expires: Dec 31, 2026
Other FDA classes: Competitive Opioid Antagonists (Mechanism)Partial Opioid Agonists (Mechanism)
Identifiers: Product ID 71872-7320_28f280a2-70d3-6846-e063-6394a90afc82SPL ID 28f280a2-70d3-6846-e063-6394a90afc82SPL set ID 28f274a4-62c4-4e54-e063-6394a90a2200RxCUI 904440UNII ZU4275277R
Pharmacologic class: Opioid Agonist/Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N471872732001 followed by a unit qualifier and the quantity

Package 71872-7320-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Label details couldn’t be retrieved right now. Open the label on DailyMed.

Other NDCs under ANDA 070918

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 070918
Product	Strength	Form · route	Labeler	Product NDC
Nalbuphine Hci	Nalbuphine hydrochloride 20 mg/mL	Injection, SolutionIntramuscular, Intravenous, Subcutaneous	HF Acquisition Co LLC, DBA HealthFirst	51662-1418
Nalbuphine Hydrochloride	Nalbuphine hydrochloride 20 mg/mL	Injection, SolutionIntramuscular, Intravenous, Subcutaneous	Hospira, Inc.	0409-1467